Search Results

Displaying Results 4076-4100 of 8030 "'III'"

Apr 07, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) 宣佈其以太幣 (ETH) 持有量達 480.3 萬枚,加密資產及現金總持有額達 114 億美元

Bitmine 為美國第 96 大最活躍交易股票,日均成交額達 9.87 億美元(5 日平均)Bitmine 持續獲得頂級機構投資者支持,包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 以及個人投資者 Thomas "Tom" Lee,攜手支持 Bitmine 收購 5% 以太幣的目標康涅狄格州諾沃克2026年4月7日

More news about: Bitmine Immersion Technologies, Inc.


Apr 07, 2026, 08:17 ET YY Group (NASDAQ: YYGH) Secures Extendable High-Level Cleaning Contract with Singapore Transportation Authority

forward-looking statement. These factors include, but are not limited to, (i) growth of the hospitality market (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business

More news about: YY Group Holding Limited


Apr 07, 2026, 08:00 ET TAE Technologies Completes Multi-State Site Evaluation Tour for First Fusion Power Plant

related thereto; (ii) the outcome of any legal proceedings that may be instituted against TMTG or TAE following announcement of the proposed transaction; (iii) the inability to complete the proposed transaction due to the failure to obtain approval of the shareholders of TMTG or TAE, or other conditions to

More news about: TAE Technologies, Inc.


Apr 07, 2026, 07:58 ET Bitmine Immersion Technologies (BMNR) maakt bekend dat de ETH-positie is gestegen tot 4,803 miljoen tokens en dat het totale bezit aan cryptovaluta en contante reserves 11,4 miljard dollar bedraagt.

Bitmine wordt ondersteund door een vooraanstaande groep institutionele investeerders, waaronder Cathie Wood van ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital en persoonlijke investeerder Thomas 'Tom' Lee ter ondersteuning van Bitmine's doel om 5% van alle ETH te verwerven.

More news about: Bitmine Immersion Technologies, Inc.


Apr 07, 2026, 07:44 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 4,803 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $11,4 Miliar

Bitmine tetap didukung oleh kelompok penting beranggotakan investor institusi seperti Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, dan investor pribadi Thomas "Tom" Lee guna mendukung tujuan Bitmine untuk mengakuisisi 5% ETH

More news about: Bitmine Immersion Technologies, Inc.


Apr 07, 2026, 07:35 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 4,803 millions de tokens et que ses avoirs en cryptomonnaies et en liquidités s'élèvent à 11,4 milliards de dollars

continue de recevoir le soutien d'un groupe d'investisseurs institutionnels de premier plan, dont Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, pour soutenir l'objectif de Bitmine visant à acquérir 5 % du nombre

More news about: Bitmine Immersion Technologies, Inc.


Apr 07, 2026, 07:24 ET 6K Additive Breaks Ground on Major Facility Expansion in Burgettstown, Powered by DPA Title III Grant and Recent IPO Capital

of its 45-acre global headquarters and manufacturing campus expansion. The project is fueled by a $23.4 million Defense Production Act (DPA) Title III grant and the successful completion of the company's Initial Public Offering (IPO) on the Australian Securities Exchange (ASX: 6KA) last December,

More news about: 6K


Apr 07, 2026, 07:00 ET Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

compatibility between ASC30 and ASC39 when combined together, with room temperature stability and a small pill size.-ASC30 is a Phase III-ready oral small molecule GLP-1R agonist that had a favorable gastrointestinal

More news about: Ascletis Pharma Inc.


Apr 07, 2026, 06:32 ET SASOL FINANCING USA LLC ANNOUNCES RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING DEBT SECURITIES

Promotion Order"), (ii) are persons falling within Article 43(2) ("members and creditors of certain bodies corporate") of the Financial Promotion Order, (iii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order,

More news about: Sasol Financing USA LLC


Apr 07, 2026, 06:00 ET Hyperscale Data's $102 Million in Cash, Restricted Cash, and Bitcoin Holdings Significantly Exceed Current Market Capitalization of Company

deeply frustrated by the market's continued failure to recognize what we believe is the obvious value on our balance sheet," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "As the Company's cash, restricted cash and Bitcoin holdings have exceeded its current market capitalization

More news about: Hyperscale Data Inc.


Apr 06, 2026, 23:28 ET Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026

bispecific antibody for cancer immunotherapy, having received marketing approval in 2022. In extensive real-world clinical practice and multiple Phase III studies, it has demonstrated clinically meaningful benefit across all patient populations regardless of PD-L1 expression status, addressing a significant

More news about: Akeso, Inc.


Apr 06, 2026, 12:12 ET Bitmine Immersion Technologies (BMNR) Công Bố Nắm Giữ 4,803 Triệu Token ETH cùng Tổng Cộng 11,4 Tỷ USD Tiền Mã Hóa và Tiền Mặt

Bitmine hiện vẫn được hỗ trợ bởi một nhóm các nhà đầu tư tổ chức hàng đầu như Cathie Wood của ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital và nhà đầu tư cá nhân Thomas "Tom" Lee nhằm giúp Bitmine đạt mục tiêu sở hữu 5% ETHNORWALK,

More news about: Bitmine Immersion Technologies, Inc.


Apr 06, 2026, 11:10 ET TIAA and Jason Day Join Forces to Help Bring Retirement Security to a New Generation

income. This figure represents all annuity income, including guaranteed and additional amounts, for all of TIAA's annuity products.iii As of December 31, 2025, assets under management across Nuveen Investments affiliates and TIAA investment management teams are $1,506 billion.TIAA-CREF

More news about: TIAA


Apr 06, 2026, 10:30 ET Digital Biomarkers Market worth $17.73 billion by 2031 | MarketsandMarkets™

conducted across therapeutic areas. Globally, more than 30,000–35,000 clinical trials are initiated each year across phases, with Phase II and Phase III trials accounting for a significant share, reflecting the need for large-scale patient monitoring and robust endpoint measurement. In parallel, clinical

More news about: MarketsandMarkets


Apr 06, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion

Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH

More news about: Bitmine Immersion Technologies, Inc.


Apr 06, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion

Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHNORWALK,

More news about: Bitmine Immersion Technologies, Inc.


Apr 06, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) gibt bekannt, dass der ETH-Bestand 4,803 Millionen Token erreicht und der Gesamtbestand an Kryptowährungen und Bargeld 11,4 Milliarden US-Dollar beträgt

wird weiterhin von einer Gruppe führender institutioneller Investoren unterstützt, darunter Cathie Wood von ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital sowie der Privatanleger Thomas „Tom" Lee, um das Ziel von Bitmine zu unterstützen, 5 % der ETH zu erwerben

More news about: Bitmine Immersion Technologies, Inc.


Apr 06, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 4,803 millones de tokens

con el respaldo de un grupo selecto de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor particular Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5% de ETH.

More news about: Bitmine Immersion Technologies, Inc.


Apr 06, 2026, 07:00 ET Clear Channel Outdoor Holdings, Inc. Commences Consent Solicitation Relating to its Senior Secured Notes

18453HAF3 and U1828LAE8); (ii) $1,150,000,000 aggregate principal amount of 7.125% Senior Secured Notes due 2031 (CUSIPs 18453HAG1 and U1828LAF5); and (iii) $900,000,000 aggregate principal amount of 7.500% Senior Secured Notes due 2033 (CUSIPs 18453HAH9 and U1828LAG3), to approve certain Proposed Amendments

More news about: Clear Channel Outdoor


Apr 06, 2026, 03:44 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

understanding of the effects of its drug candidate on patients with Osteogenesis Imperfecta ("OI"). The Company's failures were revealed by the Phase III ORBIT study in which it failed to achieve a statistically significant reduction in annualized fracture rate ("AFR"). Based on these facts, the Company's

More news about: The Schall Law Firm


Apr 06, 2026, 02:24 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE

statements to the market. Ultragenyx gave created falsely optimistic beliefs for its investors regarding the performance of its drug candidate in its Phase III trial. The Company failed to achieve statistically significant endpoints despite its optimistic communications. Based on these facts, Ultragenyx's public

More news about: DJS Law Group LLP


Apr 06, 2026, 01:17 ET Vale Base Metals Menyampaikan Hasil Eksplorasi 2025 dan Hasil Prospek 2026; Cadangan Mineral dan Sumber Daya Mineral Tembaga Meningkat 6% menjadi 53 juta ton

sektor utama: (i) Timur – 3.600 m untuk peningkatan klasifikasi sumber daya; (ii) Utara – 3.900 m untuk memperluas mineralisasi di sepanjang jurus; dan (iii) Barat – 8.500 m yang menargetkan zona bermutu tinggi yang dalam di bawah batas sumber daya pit terbuka. Hasilnya akan memberikan informasi penting untuk

More news about: Vale Base Metals


Apr 05, 2026, 13:23 ET QURE INVESTOR NOTICE: Hagens Berman Updates uniQure (QURE) Probe After FDA Criticism, Lawsuit Filed; April 13 Deadline Nears

a primary control for AMT-130.Hidden Requirements: That uniQure downplayed the necessity of a sham-controlled surgery arm for Phase III—a requirement the FDA now claims was never waived.Timeline Deception: That defendants misled investors regarding the timing of a Biologics

More news about: Hagens Berman Sobol Shapiro LLP


Apr 04, 2026, 16:00 ET RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

of the case: According to the lawsuit, defendants provided investors with material information concerning Ultragenyx's expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab (UX 143) in patients with Osteogenesis Imperfecta ("OI"). Defendants' statements included, among other

More news about: THE ROSEN LAW FIRM, P. A.


Apr 04, 2026, 12:06 ET Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP

this about: On March 13, 2026, Immutep issued a press release "announcing that the Independent Data Monitoring Committee (IDMC) for the TACTI 004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1(st) line non-small cell lung cancer has recommended the discontinuation of the trial following

More news about: THE ROSEN LAW FIRM, P. A.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.